19 employees
Medicenna is a clinical stage, privately held, immuno-oncology company.
2012
$1.9M
from 1 investors over 1 rounds
Medicenna Therapeutics Corp. raised $1.9M on July 9, 2019
Investors: Cancer Prevention and Research Institute of Texas